vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and MEDALLION FINANCIAL CORP (MFIN). Click either name above to swap in a different company.
MEDALLION FINANCIAL CORP is the larger business by last-quarter revenue ($70.6M vs $62.1M, roughly 1.1× Cytek Biosciences, Inc.). MEDALLION FINANCIAL CORP runs the higher net margin — 17.3% vs -70.9%, a 88.2% gap on every dollar of revenue. On growth, MEDALLION FINANCIAL CORP posted the faster year-over-year revenue change (25.4% vs 8.1%). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 15.0%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Mahindra & Mahindra Financial Services Limited (MMFSL) is an Indian rural non-banking financial company headquartered in Mumbai. It is amongst the top tractor financers in India, with 1000+ offices across the country.
CTKB vs MFIN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $70.6M |
| Net Profit | $-44.1M | $12.2M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 29.3% |
| Net Margin | -70.9% | 17.3% |
| Revenue YoY | 8.1% | 25.4% |
| Net Profit YoY | -557.1% | 20.3% |
| EPS (diluted) | — | $0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $70.6M | ||
| Q3 25 | $52.3M | $58.7M | ||
| Q2 25 | $45.6M | $62.6M | ||
| Q1 25 | $41.5M | $63.0M | ||
| Q4 24 | $57.5M | $56.3M | ||
| Q3 24 | $51.5M | $53.3M | ||
| Q2 24 | $46.6M | $51.0M | ||
| Q1 24 | $44.9M | $53.3M |
| Q4 25 | $-44.1M | $12.2M | ||
| Q3 25 | $-5.5M | $7.8M | ||
| Q2 25 | $-5.6M | $11.1M | ||
| Q1 25 | $-11.4M | $12.0M | ||
| Q4 24 | $9.6M | $10.1M | ||
| Q3 24 | $941.0K | $8.6M | ||
| Q2 24 | $-10.4M | $7.1M | ||
| Q1 24 | $-6.2M | $10.0M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 29.3% | ||
| Q3 25 | -17.6% | 33.2% | ||
| Q2 25 | -23.3% | 31.1% | ||
| Q1 25 | -36.1% | 32.1% | ||
| Q4 24 | 5.2% | 32.8% | ||
| Q3 24 | -8.2% | 26.6% | ||
| Q2 24 | -18.3% | 24.3% | ||
| Q1 24 | -23.9% | 33.6% |
| Q4 25 | -70.9% | 17.3% | ||
| Q3 25 | -10.5% | 13.2% | ||
| Q2 25 | -12.2% | 17.7% | ||
| Q1 25 | -27.5% | 19.1% | ||
| Q4 24 | 16.8% | 18.0% | ||
| Q3 24 | 1.8% | 16.1% | ||
| Q2 24 | -22.4% | 13.9% | ||
| Q1 24 | -13.8% | 18.8% |
| Q4 25 | — | $0.50 | ||
| Q3 25 | — | $0.32 | ||
| Q2 25 | — | $0.46 | ||
| Q1 25 | — | $0.50 | ||
| Q4 24 | — | $0.43 | ||
| Q3 24 | — | $0.37 | ||
| Q2 24 | — | $0.30 | ||
| Q1 24 | — | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $136.3M |
| Total DebtLower is stronger | — | $216.0M |
| Stockholders' EquityBook value | $341.7M | $408.6M |
| Total Assets | $461.5M | $3.0B |
| Debt / EquityLower = less leverage | — | 0.53× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $136.3M | ||
| Q3 25 | $93.3M | $72.5M | ||
| Q2 25 | $75.5M | $110.4M | ||
| Q1 25 | $95.3M | $131.5M | ||
| Q4 24 | $98.7M | $98.2M | ||
| Q3 24 | $162.3M | $120.6M | ||
| Q2 24 | $177.9M | $87.7M | ||
| Q1 24 | $168.8M | $54.8M |
| Q4 25 | — | $216.0M | ||
| Q3 25 | — | $215.7M | ||
| Q2 25 | — | $199.9M | ||
| Q1 25 | — | $199.7M | ||
| Q4 24 | — | $232.2M | ||
| Q3 24 | — | $232.0M | ||
| Q2 24 | — | $230.8M | ||
| Q1 24 | — | $225.6M |
| Q4 25 | $341.7M | $408.6M | ||
| Q3 25 | $378.6M | $397.4M | ||
| Q2 25 | $377.6M | $389.9M | ||
| Q1 25 | $379.6M | $380.2M | ||
| Q4 24 | $395.7M | $370.2M | ||
| Q3 24 | $385.5M | $362.4M | ||
| Q2 24 | $389.1M | $354.0M | ||
| Q1 24 | $392.6M | $349.0M |
| Q4 25 | $461.5M | $3.0B | ||
| Q3 25 | $494.9M | $2.9B | ||
| Q2 25 | $493.3M | $2.9B | ||
| Q1 25 | $482.6M | $2.8B | ||
| Q4 24 | $499.5M | $2.9B | ||
| Q3 24 | $491.2M | $2.9B | ||
| Q2 24 | $483.7M | $2.8B | ||
| Q1 24 | $492.1M | $2.6B |
| Q4 25 | — | 0.53× | ||
| Q3 25 | — | 0.54× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 0.53× | ||
| Q4 24 | — | 0.63× | ||
| Q3 24 | — | 0.64× | ||
| Q2 24 | — | 0.65× | ||
| Q1 24 | — | 0.65× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $126.3M |
| Free Cash FlowOCF − Capex | $-1.8M | — |
| FCF MarginFCF / Revenue | -2.9% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | — | 10.35× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $126.3M | ||
| Q3 25 | $-3.9M | $67.0M | ||
| Q2 25 | $108.0K | $-10.7M | ||
| Q1 25 | $-125.0K | $36.3M | ||
| Q4 24 | $2.0M | $108.7M | ||
| Q3 24 | $13.2M | $24.6M | ||
| Q2 24 | $6.2M | $27.6M | ||
| Q1 24 | $4.0M | $32.3M |
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-4.6M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-974.0K | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $12.2M | — | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $3.4M | — |
| Q4 25 | -2.9% | — | ||
| Q3 25 | -8.7% | — | ||
| Q2 25 | -3.2% | — | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 23.7% | — | ||
| Q2 24 | 11.0% | — | ||
| Q1 24 | 7.6% | — |
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | 1.3% | — |
| Q4 25 | — | 10.35× | ||
| Q3 25 | — | 8.63× | ||
| Q2 25 | — | -0.97× | ||
| Q1 25 | — | 3.02× | ||
| Q4 24 | 0.21× | 10.72× | ||
| Q3 24 | 14.05× | 2.86× | ||
| Q2 24 | — | 3.89× | ||
| Q1 24 | — | 3.22× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
MFIN
Segment breakdown not available.
